Clinical Trial Update: Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety of Asoprisnil in the treatment of uterine fibroids has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding
• Irregular Uterine Bleeding
• Uterine Fibroids

Drugs mentioned

• Asoprisnil (asoprisnil)

Snippet

Sponsor: Abbott | Conditions: Leiomyoma, Menorrhagia | Phase 3 | Status: COMPLETED